NOBO Medicine
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's Lymphoma (NCT07114367) | NOBO Medicine | 2025-12-02 |
| NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL (NCT06737250) | NOBO Medicine | 2024-11-25 |
Track NOBO Medicine automatically
Every clearance here is in the API, with alerts when new ones post.